Lymphocytic and collagenous colitis in children and adolescents: Comprehensive clinicopathologic analysis with long-term follow-up.


Journal

Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547

Informations de publication

Date de publication:
12 2020
Historique:
received: 10 08 2020
revised: 20 09 2020
accepted: 21 09 2020
pubmed: 30 9 2020
medline: 30 3 2021
entrez: 29 9 2020
Statut: ppublish

Résumé

Microscopic colitis (MC) is characterized by chronic watery diarrhea, endoscopically normal findings, and abnormal histology. While mostly encountered in adults, pediatric cases are rare and may show varying presentations. Our pathology data system was searched from 1984 to 2019 for patients ≤18 years of age with a lymphocytic colitis (LC) or collagenous colitis (CC) pattern of injury. Twenty-seven cases (23 LC and 4 CC) were retrieved. LC was more prevalent than CC (85% vs 15%, respectively) and affected slightly younger individuals (mean, 9.8 years versus 12.25 years). Immune dysregulation was documented in 11 (41%) patients. Most patients presented with watery diarrhea (n = 26, 96%) and either abdominal pain (n = 18, 67%), nausea/vomiting (n = 5, 19%), flatulence (n = 6, 22%), and/or weight loss (n = 1, 4%). A subset of patients (n = 10, 37%) demonstrated endoscopic abnormalities. Histologically, some patients with LC and CC displayed focal cryptitis or crypt abscess formation (n = 7, 26%) and focally increased crypt apoptosis (n = 9, 33%) in the absence of chronic injury. Clinical follow-up data were available for 23 (85%) patients with variable clinical responses recorded. Only 8 patients experienced complete symptom resolution. Twelve patients (11 LC and 1 CC) had subsequent biopsy material; of which, one developed histologic features of inflammatory bowel disease and another was found to have a CTLA-4 deficiency. Our study shows that pediatric patients with MC may have atypical clinical, histologic, and endoscopic findings and variable clinical responses. Underlying inflammatory and/or genetic conditions may be eventually unmasked, and genetic testing may be helpful in a small subset of patients.

Identifiants

pubmed: 32991931
pii: S0046-8177(20)30183-0
doi: 10.1016/j.humpath.2020.09.011
pii:
doi:

Substances chimiques

CTLA-4 Antigen 0
CTLA4 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-22

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Annika L Windon (AL)

Department of Pathology and Laboratory Medicine, The Johns Hopkins Hospital, 1800 Orleans Street, Baltimore, MD, 21287, USA. Electronic address: annika.windon@vumc.org.

Erik Almazan (E)

Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD, 21205, USA. Electronic address: erikalmazan@jhmi.edu.

Maria Oliva-Hemker (M)

Division of Pediatric Gastroenterology, Hepatology, and Nutrition, The Johns Hopkins Hospital, 200 N. Wolfe Street, Rubenstein Child Health Building, Baltimore, MD, 21287, USA. Electronic address: moliva@jhmi.edu.

Danielle Hutchings (D)

Department of Pathology and Laboratory Medicine, The Johns Hopkins Hospital, 1800 Orleans Street, Baltimore, MD, 21287, USA. Electronic address: Danille.Hutchings@cshs.org.

Naziheh Assarzadegan (N)

Department of Pathology and Laboratory Medicine, The Johns Hopkins Hospital, 1800 Orleans Street, Baltimore, MD, 21287, USA. Electronic address: nassarz1@jh.edu.

Kevan Salimian (K)

Department of Pathology and Laboratory Medicine, The Johns Hopkins Hospital, 1800 Orleans Street, Baltimore, MD, 21287, USA. Electronic address: ksalimi1@jhmi.edu.

Elizabeth A Montgomery (EA)

Department of Pathology and Laboratory Medicine, The Johns Hopkins Hospital, 1800 Orleans Street, Baltimore, MD, 21287, USA. Electronic address: eam305@med.miami.edu.

Lysandra Voltaggio (L)

Department of Pathology and Laboratory Medicine, The Johns Hopkins Hospital, 1800 Orleans Street, Baltimore, MD, 21287, USA. Electronic address: lvoltag1@jhmi.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH